Rudolf Pihusch
Overview
Explore the profile of Rudolf Pihusch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein-Scory S, Baraniskin A, Schmiegel W, Mika T, Schroers R, Held S, et al.
Mol Oncol
. 2024 Dec;
19(2):344-356.
PMID: 39630848
The randomized FIRE-4.5 (AIO KRK0116) trial compared first-line therapy with FOLFOXIRI (folinic acid, fluorouracil, oxaliplatin, and irinotecan) plus either cetuximab or bevacizumab in B-Raf proto-oncogene, serine/threonine kinase (BRAF) V600E-mutant metastatic...
2.
Stintzing S, Heinrich K, Tougeron D, Modest D, Schwaner I, Eucker J, et al.
J Clin Oncol
. 2023 Jun;
41(25):4143-4153.
PMID: 37352476
Purpose: mutation is associated with a poor outcome in metastatic colorectal cancer (mCRC). This clinical trial investigated the efficacy of triplet chemotherapy (fluorouracil, folinic acid, oxaliplatin, and irinotecan) combined with...
3.
Hollein A, Bojko P, Schulz S, Neitz J, Stotzer O, Pihusch R, et al.
Acta Oncol
. 2021 Jan;
60(1):24-27.
PMID: 33397179
No abstract available.
4.
Rank A, Nieuwland R, Toth B, Pihusch V, Delker R, Hiller E, et al.
Transplantation
. 2011 Jun;
92(2):244-50.
PMID: 21629178
Background: The differentiation between acute graft-versus-host disease (aGvHD) and infection is still a clinical challenge in patients after allogeneic hematopoietic stem-cell transplantation (HSCT). Definitive diagnosis is based on histologic findings,...
5.
Rank A, Nieuwland R, Delker R, Pihusch V, Wilkowski R, Toth B, et al.
Clin Transplant
. 2011 Feb;
25(3):E233-42.
PMID: 21303416
Increasing evidence suggests that circulating microparticles (MP) exposing CD61 originate predominantly from megakaryocytes. Dramatic changes in megakaryocytic homeostasis are regularly observed following allogeneic hematopoietic stem cell transplantation (HSCT) and associated...
6.
Rank A, Nieuwland R, Delker R, Kohler A, Toth B, Pihusch V, et al.
Thromb Res
. 2010 Aug;
126(4):e255-9.
PMID: 20696467
Introduction: Microparticles (MP), presumably of platelet origin, are the most abundant microparticles in blood. To which extent such MP may also directly originate from megakaryocytes, however, is unknown. During hematopoietic...
7.
Schnittger S, Bacher U, Haferlach C, Beelen D, Bojko P, Burkle D, et al.
Haematologica
. 2008 Nov;
94(1):141-4.
PMID: 19029146
No abstract available.
8.
Astner S, Pihusch R, Nieder C, Rachinger W, Lohner H, Tonn J, et al.
Anticancer Res
. 2007 Jan;
26(6C):4917-20.
PMID: 17214362
Cases of extracranial metastases of glioblastoma multiforme to sites such as bones, spleen, lung, liver and kidneys have been reported but available information about treatment of organ and bone metastases...
9.
Pihusch V, Rank A, Steber R, Pihusch M, Pihusch R, Toth B, et al.
Transplantation
. 2006 May;
81(10):1405-9.
PMID: 16732177
Background: Alterations of microparticles derived from different cell types are described in a number of diseases associated with inflammation and hemostatic disorders. Methods: In this prospective study, we firstly analyzed...
10.
Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb H, et al.
Eur J Haematol
. 2006 Jan;
76(2):93-101.
PMID: 16405429
Background: Prompt detection of transplant-related complications (TRC) as infections, acute graft-versus-host disease (aGVHD), microangiopathic hemolytic anemia, or veno-occlusive disease following allogeneic hematopoietic stem cell transplantation (HSCT) is essential. Patients And...